The FTC is focusing its attention on the listing of pharmaceutical patents in the FDA’s Orange Book.
Patent listing may be the subject of FTC inquiry even absent infringement litigation enforcing the relevant patents....more
The U.S. Court of Appeals for the Second Circuit affirmed a grant of summary judgment on July 19, 2018, in favor of defendants in a nearly decade-old case alleging an unlawful conspiracy in the single-copy magazine industry....more
8/8/2018
/ Antitrust Conspiracies ,
Antitrust Litigation ,
Appeals ,
Boycotts ,
Corporate Counsel ,
Determination on Remand ,
Discovery ,
Dismissals ,
Evidence ,
Expert Reports ,
Magazines ,
Publishers ,
Reaffirmation ,
Retailers ,
Reversal ,
Sherman Act ,
Summary Judgment ,
Wholesale